Department of Surgery
University of Wisconsin School of Medicine and Public Health

Specialties

Ashley Woodfin, MD

Assistant Professor

  • Division of Surgical Oncology

woodfin@surgery.wisc.edu
(608) 265-7030

Education

  • MD, Oakland University William Beaumont School of Medicine, Rochester, MI
  • Residency, General Surgery, Rush University Medical Center, Chicago, IL
  • Fellowship, Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX

Clinical Specialties

Dr. Woodfin specializes in breast surgery with a focus on benign and malignant breast disease. She is certified by the American Board of Surgery.

Dr. Woodfin provides a wide range of services including Axillary Lymph Node Dissection, Core Needle Biopsy, Lumpectomy or Partial Mastectomy, Modified Radical Mastectomy, Needle-localized Excision, Sentinel Lymph Node Biopsy, Simple Mastectomy, Skin-sparing and/or Nipple-sparing Mastectomy.

Research Interests

Dr. Woodfin’s principal research interests include the de-escalation of axillary surgery and surgical treatment after neoadjuvant systemic therapy in breast cancer patients. She also is interested in outcomes based projects focused on quality improvement and surgical education of fellows, residents, and medical students related to breast surgery oncology.

Recent Publications

  • Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks.
    Singh P, Agnese DM, Amin M, Barrio AV, van den Bruele AB, Burke EE, Danforth DN, Dirbas FM, Eladoumikdachi F, Fayanju OM, Kantor O, Kumar S, Lee MC, Matsen C, Nguyen TT, Ozmen T, Park KU, Plichta JK, Reyna C, Showalter SL, Styblo T, Tranakas N, Weiss A, Woodfin A, Laronga C, Boughey JC
    Ann Surg Oncol 2025 Feb; 32(2): 899-911
    [PubMed ID: 39538100]

  • ASO Visual Abstract: Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer.
    Woodfin AA, Yam C, Teshome M, Kuerer HM, Hunt KK, Meric-Bernstam F, Schaverien M, Barcenas CH, Sun SX
    Ann Surg Oncol 2024 Apr; 31(4): 2278-2279
    [PubMed ID: 38206502]

  • Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer.
    Woodfin AA, Yam C, Teshome M, Kuerer HM, Hunt KK, Meric-Bernstam F, Schaverien M, Barcenas CH, Sun SX
    Ann Surg Oncol 2024 Feb; 31(2): 974-980
    [PubMed ID: 37973647]

  • Evidence-Based Strategies to Minimize the Likelihood of Axillary Lymph Node Dissection in Clinically Node-Positive Patients Following Neoadjuvant Chemotherapy.
    Woodfin AA, Caudle AS
    Surg Oncol Clin N Am 2023 Oct; 32(4): 693-703
    [PubMed ID: 37714637]

  • Trends in Antibiotic Duration for Complicated Intra-Abdominal Infections : Adaptation to Current Guidelines.
    DeCesare L, Xu TQ, Saclarides C, Coughlin JM, Chivukula SV, Woodfin A, Chan E, Booker C, Jacobson R
    Am Surg 2021 Jan; 87(1): 120-124
    [PubMed ID: 32845728]

All Publications on PubMed